To evaluate the efficacy and patient preferences of ear lobe capillary glycemia (GC) against conventional fingerstick GC, we studied 40 patients (13M/27F; 41.6 +/- 13.5 years) with type 2 diabetes mellitus (DM2). Glucose monitoring was accomplished using a digital glucometer and Accu-Chek Softclix Pro lancetator. Tests were carried out during 27 days with grade 2 of penetration (median) on the distal phalange of the right hand's third finger and on the inferior part of the right ear lobe, at the same time and fasting. The comparative analyzes of fingerstick and ear lobe GC did not show statistical significance (p = 0.008). 72.5% of patients reported no pain during the ear lobe test against 15% in fingerstick GC. There was a significant correlation between ear lobe test and low level of pain (p< 0.001). 82.5% of patients preferred the ear lobe test for monitoring. The ear lobe GC was as efficient as traditional fingerstick test. This new method was associated with low level of pain, safety, comfort, and good acceptance for most patients.
Psychological aspects and patients' acceptance of type 1 diabetes (DM1) may exercise some influence in their glycemic control. In this project the influence of psychological aspects were evaluated on glycemic control of DM1 patients. A retrospective study of participants from Diabetes Weekend (DW), an educational project in DM1 was carried out in Minas Gerais. In a sample of 150 subjects (66M/84F, 21.6+/-13.5 years and duration of DM of 8.5+/-7.9 years) we analyzed: type of insulin, insulin delivery, insulin dose per day and insulin dose per day in DW, psychological profile, capillary glycemia and previous history of convulsion crisis, severe hypoglycemia or diabetic ketoacidosis (CAD). Glucose was monitored 4 times a day by a digital glucose monitor. 20.9% of the patients with DM1 felt very well (G1); 39.5% well (G2), 25.6% with difficult glycemic control (G3), 9.3% trying to accept (G4) and 4.7% reported to be very bad about their DM1. The average capillary glycemia (ACG, in mg/dl) was significantly lower in G1 than in the others (169.8; G2: 182.3; G3: 199.3; G4: 200.7). There were no significant association of this psychological aspects and previous history of CAD, hypoglycemia or convulsion crisis. DM1 duration over 5 years was associated to lower acceptance of the disease (p= 0.017) and age of patients (p= 0.000). 13.9% of patients reported to be ashamed of their disease; the ACG was significantly higher in this group as compared to others (246.2 vs. 178.1; p= 0.007). In 91 patients (60.4%) who mention to have apprehension of feeling sick in public the ACG was significantly higher (200.4 vs. 184.5; p= 0.014). The systematic glucose monitoring showed positive association between psychological aspects and worse glycemic control. The psychological and multidisciplinary approach of DM1 patients is very important to try to improve the metabolic control, to prevent future complications, which results in better quality of life for these patients.
Arq Bras Endocrinol Metab vol 46 nº 5 Outubro 2002 RESUMOA educação em diabetes é parte imprescindível do tratamento do paciente, associado ao controle metabólico adequado, atividade físi-ca e dieta. O maior nível de conhecimento sobre a doença e suas complicações estão relacionadas a uma melhora da qualidade de vida, com redução do número de crises de hipoglicemia, menor número de internações hospitalares, melhor controle metabólico e maior aceitação da doença. Apresenta-se uma proposta de educação em diabetes na forma de colônia de fim de semana associada a educação via internet, através do projeto educacional Diabetes Weekend. Objetiva-se informar e alertar médicos e educadores da área de saúde da importância da educação em forma de colônia de fim de semana na prevenção de complicações agudas e crônicas do diabetes mellitus tipo 1 e seu impacto sobre a qualidade de vida dos pacientes. Education is essential for treatment of the diabetic patient. Adequate treatment involves good glycemic control, regular exercises, specific diet and education. High-level knowledge of diabetes is shown to reduce hypoglycemic episodes, chronic complications, and to increase acceptance of this disease and metabolic control, resulting in a better quality of life. Our experience with diabetes education is presented in this article. The major targets are to update, guide and elicit the doubts from health professionals regarding this recent and effective form of education in type 1 diabetes mellitus. The outcomes on quality of life for diabetic patient are discussed. ODIABETES MELLITUS (DM) é uma doença crônica, grave, de evolução lenta e progressiva, que acomete milhares de pessoas em todo mundo, necessitando de tratamento intensivo e orientação médica adequada. Após a conclusão do maior estudo envolvendo diabéticos tipo 1, o DCCT (Diabetes Control and Complications Trial) determinou que o tratamento disciplinado no DM tipo 1 permite prevenir ou retardar as complicações agudas e crônicas da doença (1). Para isso, é preciso um envolvimento harmonioso e contínuo de pacientes, família e profissionais de saúde, na busca de se atingir o equilíbrio biológico, psíquico e social do indivíduo (2).
RESUMOÉ relatado o caso de paciente de 26 anos que apresentou sinais e sintomas compatíveis com hipertireoidismo, encaminhado para propedêutica endocrinológica. Após 3 meses de evolução, o paciente apresentou hipertensão arterial sistêmica grave. Diante de um paciente jovem, sem história familiar de hipertensão e ausência de outras co-morbidades, foi aventada a hipótese de hipertensão endócrina, e, ainda que rara, neoplasia endócrina múltipla tipo 2. A propedêutica solicitada demonstrou a presença de feocromocitoma bilateral associado a carcinoma medular de tireóide e adenoma de paratireóide. O diagnóstico precoce permitiu a realização do tratamento adequado com evolução favorável do quadro. Os autores discutem as condutas diagnósticas e terapêuticas na neoplasia endócrina múltipla tipo 2. Objetiva-se atualizar, orientar e esclarecer dúvidas dos profissionais a respeito desses fatores. This 26-years-old male presented with signs and symptoms of hyperthyroidism and was submitted to an endocrine evaluation. After 3 mo, the patient developed severe systemic hypertension. There was no family history of hypertension or other diseases. Endocrine hypertension and a rare syndrome of multiple endocrine neoplasia (MEN) type 2 were diagnosed. The evaluation disclosed the presence of bilateral pheochromocytoma, medullary thyroid carcinoma and parathyroid adenoma. The early diagnosis led to specific treatment and a favorable evolution in this case. Diagnostic and therapeutic management of MEN type 2 are discussed. This study aimed to update, guide and answer some questions of professionals regarding this factors. , descritas por Sipple, que verificou a presença de feocromocitoma, carcinoma medular de tireóide (CMT) e hiperparatireoidismo primário (HPTP) em um mesmo paciente (1). É um quadro crônico, relativamente raro, determinado por uma herança autossômica dominante, ocorrendo na forma esporádica em pequena parte dos casos (1).A MEN-2 subdivide-se em três síndromes: MEN-2 A, MEN-2B e o carcinoma medular de tireóide familiar. Acomete homens e mulheres em proporções semelhantes, já tendo sido descrita em todas as idades, com incidência estimada em 1 para cada 30.000 indivíduos. apresentação de casos
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.